Atrás
Rango del Día
$22.63
$23.57
Rango de 52 Semanas
$5.89
$55.65
Volumen
20,341
Promedio 50D / 200D
$25.90
/
$31.71
Cierre Anterior
$23.54
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 423.0 | 0.4 |
| P/B | 58.4 | 2.9 |
| ROE % | 14.8 | 3.7 |
| Net Margin % | 29.0 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
No hay estimaciones futuras disponibles
Puntos Clave
ROE of 14.83% — decent returns on equity
Net margin of 28.99% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 2.08M in free cash flow
P/E of 423.03 — premium valuation
PEG of 0.40 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)21.95%
Earnings (1Y)5.29%
FCF Growth (3Y)-31.62%
Calidad
Return on Equity
14.83%
ROIC8.71%
Net Margin28.99%
Op. Margin24.38%
Seguridad
Debt / Equity
0.00
Current Ratio10.71
Interest Coverage0.00
Valoración
P/E Ratio
423.03
P/B Ratio58.39
EV/EBITDA497.17
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.95% | Revenue Growth (3Y) | -41.04% |
| Earnings Growth (1Y) | 5.29% | Earnings Growth (3Y) | -51.32% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 8.19M | Net Income (TTM) | 2.37M |
| ROE | 14.83% | ROA | 12.54% |
| Gross Margin | 71.90% | Operating Margin | 24.38% |
| Net Margin | 28.99% | Free Cash Flow (TTM) | 2.08M |
| ROIC | 8.71% | FCF Growth (3Y) | -31.62% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 10.71 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 423.03 | P/B Ratio | 58.39 |
| P/S Ratio | 122.64 | PEG Ratio | 0.40 |
| EV/EBITDA | 497.17 | Dividend Yield | 0.00% |
| Market Cap | 1.00B | Enterprise Value | 992.03M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 8.19M | 6.71M | 23.54M | 4.43M |
| Net Income | 2.37M | 2.25M | 10.01M | 2.54M |
| EPS (Diluted) | 0.06 | 0.01 | 0.07 | 0.03 |
| Gross Profit | 5.89M | 3.36M | 12.56M | 2.54M |
| Operating Income | 2.00M | 1.96M | 10.20M | 2.46M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Total Assets | 18.92M | 15.81M | 13.96M | 4.92M |
| Total Liabilities | 1.73M | 993,060.0 | 1.41M | 2.38M |
| Shareholders' Equity | 17.19M | 14.82M | 12.55M | 2.54M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 11.76M | 9.69M | 7.10M | 4.18M |
| Current Assets | 18.53M | 15.75M | 13.94M | 4.92M |
| Current Liabilities | 1.73M | 993,060.0 | 1.41M | 2.38M |